$HUN

Huntsman earnings missed by $0.03, revenue topped estimates

Huntsman (HUN) reported Q3 EPS of $0.04, missing estimates by $0.03, but revenue of $1.72B topped expectations. The stock is down 1.87% over 3 months but up 24.22% year-over-year. Analysts have mixed EPS revisions, and InvestingPro rates its financial health as 'good performance.'

Original reporting
Published Nov 2, 2026, 9:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 9:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$HUN
Bearish
high confidence
Mentioned
$HUN
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$HUNBearishMed
01

Why it matters

The earnings miss may trigger a modest decline in HUN shares, while the revenue beat could mitigate downside.

02

Market read

First‑time earnings disclosure provides new data for traders; potential short‑term price impact.

03

What to watch

Management commentary on future guidance or cost controls was not provided, leaving upside potential uncertain.

Relevance 7/10Novelty 7/10Timing: after-hours

Background

Huntsman Corp (NYSE:HUN) released its third‑quarter earnings, showing a slight EPS miss but revenue above consensus.

Company-level read

Ticker impact

$HUNBearishHigh confidence
Context

Huntsman reported Q3 EPS of $0.04, missing estimates by $0.03 and revenue of $1.72B versus $1.61B consensus.

Expected impact

likely pressure as investors price in the EPS miss

Evidence & confidence

The surprise EPS shortfall is a fresh data point that can trigger sell pressure in the near term.

Market effects

Chemicals sector may see modest re‑rating as peers compare earnings performance.

U.S. market participants may adjust short‑term positioning in specialty chemicals.

Limited to investors tracking U.S. listed specialty chemical stocks.

Counterpoint

Despite the EPS miss, the revenue beat could support a short‑term bounce if the market focuses on top‑line growth.

Key entities

  • Huntsman Corp

    Specialty chemicals manufacturer reporting Q3 results.

Related articles

$HUNMed

Huntsman Q3 Earnings Call Highlights

Huntsman (HUN) reported Q3 earnings, noting seasonal slowing and higher raw-material costs in North American MDI markets. The company expects 2027 industry MDI growth to be flat to 2% and sees growth opportunities in advanced materials and automotive applications. Huntsman generated $82M in free cash flow in Q3 and anticipates substantial cash inflow in Q4. Europe remains challenging due to high energy costs, while China's market shows stability.

$HUNMed

Huntsman Corp (HUN) (Q3 2026) Earnings Call Highlights: $100 Million EBITDA Boost

Huntsman Corp (HUN) reported a $100M EBITDA boost in Q3 2026, with CEO Peter Huntsman expressing confidence in meeting $300M synergy targets from the Olin merger. He discussed market positioning, cost management, and growth expectations, including GDP-plus growth in Advanced Materials through 2027. The company expects to cover its dividend and capex with operating cash flow, despite minimal cash flow in the first nine months.

$HUNMedAI 8/10

Huntsman: Q3 Earnings Snapshot

Huntsman Corp. (HUN) reported a Q3 loss of $18M, or 10 cents per share, missing analyst expectations of 7 cents per share. Adjusted earnings were 4 cents per share. Revenue was $1.72B, exceeding forecasts of $1.6B.